NCT00003449 2014-05-22
Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer
University of Southern California
Phase 2 Completed
University of Southern California
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.